Cardax Overview
- Year Founded
-
2006
- Status
-
Public
- Employees
-
20
- Stock Symbol
-
CDXI
Cardax General Information
Description
Cardax Inc is a life sciences company engaged in the development of marketing, and distribution of consumer health products in the United States. The firm's platform has applications in arthritis, metabolic syndrome, liver disease, and cardiovascular disease, as well as macular degeneration and prostate disease. It is focused on the development of astaxanthin technologies. The group's product ZanthoSyn is marketed as a novel astaxanthin dietary supplement. Astaxanthin is a clinically studied ingredient with a safe anti-inflammatory activity that supports joint health, cardiovascular health, metabolic health, and liver health. Geographically, it generates maximum revenue from the United States.
Contact Information
Website
www.cardaxpharma.comCorporate Office
- 2800 Woodlawn Drive
- Suite 129
- Honolulu, HI 96822
- United States
Corporate Office
- 2800 Woodlawn Drive
- Suite 129
- Honolulu, HI 96822
- United States
Cardax Stock Performance
(As of Tuesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| 482.33 |
Cardax Financials Summary
As of 31-Mar-2021, Cardax has a trailing 12-month revenue of $501K.
|
In Thousands, USD |
TTM 31-Mar-2021 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 | FY 2018 31-Dec-2018 |
|---|---|---|---|---|
| EV | 5,945 | 5,525 | 9,350 | 26,469 |
| Revenue | 501 | 539 | 711 | 1,511 |
| EBITDA | (3,026) | (2,636) | (4,430) | (3,991) |
| Net Income | (5,435) | (5,056) | (5,093) | (4,024) |
| Total Assets | 1,378 | 1,425 | 2,019 | 2,459 |
| Total Debt | 5,395 | 4,784 | 2,597 | 0 |
Cardax Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Cardax Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
Cardax Comparisons
Industry
Financing
Details
Cardax Competitors (10)
One of Cardax’s 10 competitors is Boehringer Ingelheim, a Corporation company based in Ingelheim Am Rhein, Germany.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Boehringer Ingelheim | Corporation | Ingelheim Am Rhein, Germany | ||||
| Astellas Pharma | Corporation | Tokyo, Japan | ||||
| Alkeus Pharmaceuticals | Venture Capital-Backed | Cambridge, MA | ||||
| Grace Therapeutics | Corporation | Princeton, NJ | ||||
| Amarin | Corporation | Bedminster Township, NJ |
Cardax Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Cardax Patents
Cardax Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20220380306-A1 | Astaxanthin esters and methods of use thereof | Pending | 27-Sep-2019 | ||
| EP-4034525-A1 | Astaxanthin esters and methods of use thereof | Inactive | 27-Sep-2019 | ||
| EP-4034525-A4 | Astaxanthin esters and methods of use thereof | Inactive | 27-Sep-2019 | ||
| US-20200085776-A1 | Methods of reducing c-reactive protein and/or treating cardiovascular disease | Inactive | 10-Sep-2018 | ||
| US-8063101-B2 | Carotenoid analogs and derivatives for the prevention of platelet aggregation | Inactive | 23-Mar-2007 | A61K31/01 |
Cardax Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Cardax Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Cardax FAQs
-
When was Cardax founded?
Cardax was founded in 2006.
-
Where is Cardax headquartered?
Cardax is headquartered in Honolulu, HI.
-
What is the size of Cardax?
Cardax has 20 total employees.
-
What industry is Cardax in?
Cardax’s primary industry is Drug Discovery.
-
Is Cardax a private or public company?
Cardax is a Public company.
-
What is Cardax’s stock symbol?
The ticker symbol for Cardax is CDXI.
-
What is Cardax’s current revenue?
The trailing twelve month revenue for Cardax is $501K.
-
Who are Cardax’s competitors?
Boehringer Ingelheim, Astellas Pharma, Alkeus Pharmaceuticals, Grace Therapeutics, and Amarin are some of the 10 competitors of Cardax.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
